Literature DB >> 32304324

Elucidating the unusual reaction kinetics of D-glucuronyl C5-epimerase.

Deepika Vaidyanathan1,2, Elena Paskaleva2, Troy Vargason2,3, Xia Ke2,4, Scott A McCallum2, Robert J Linhardt1,2,4,5, Jonathan S Dordick1,2,3,5.   

Abstract

The chemoenzymatic synthesis of heparin, through a multienzyme process, represents a critical challenge in providing a safe and effective substitute for this animal-sourced anticoagulant drug. D-glucuronyl C5-epimerase (C5-epi) is an enzyme acting on a heparin precursor, N-sulfoheparosan, catalyzing the reversible epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA). The absence of reliable assays for C5-epi has limited elucidation of the enzymatic reaction and kinetic mechanisms. Real time and offline assays are described that rely on 1D 1H NMR to study the activity of C5-epi. Apparent steady-state kinetic parameters for both the forward and the pseudo-reverse reactions of C5-epi are determined for the first time using polysaccharide substrates directly relevant to the chemoenzymatic synthesis and biosynthesis of heparin. The forward reaction shows unusual sigmoidal kinetic behavior, and the pseudo-reverse reaction displays nonsaturating kinetic behavior. The atypical sigmoidal behavior of the forward reaction was probed using a range of buffer additives. Surprisingly, the addition of 25 mM each of CaCl2 and MgCl2 resulted in a forward reaction exhibiting more conventional Michaelis-Menten kinetics. The addition of 2-O-sulfotransferase, the next enzyme involved in heparin synthesis, in the absence of 3'-phosphoadenosine 5'-phosphosulfate, also resulted in C5-epi exhibiting a more conventional Michaelis-Menten kinetic behavior in the forward reaction accompanied by a significant increase in apparent Vmax. This study provides critical information for understanding the reaction kinetics of C5-epi, which may result in improved methods for the chemoenzymatic synthesis of bioengineered heparin.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 N-sulfoheparosan; 2-O-sulfotransferase; C5-epimerase; divalent cations; enzyme kinetics

Year:  2020        PMID: 32304324      PMCID: PMC7581656          DOI: 10.1093/glycob/cwaa035

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  31 in total

1.  Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase.

Authors:  B E Crawford; S K Olson; J D Esko; M A Pinhal
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

2.  Structural and functional study of D-glucuronyl C5-epimerase.

Authors:  Yi Qin; Jiyuan Ke; Xin Gu; Jianping Fang; Wucheng Wang; Qifei Cong; Jie Li; Jinzhi Tan; Joseph S Brunzelle; Chenghai Zhang; Yi Jiang; Karsten Melcher; Jin-ping Li; H Eric Xu; Kan Ding
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

3.  Biosynthesis of heparin/heparan sulfate: kinetic studies of the glucuronyl C5-epimerase with N-sulfated derivatives of the Escherichia coli K5 capsular polysaccharide as substrates.

Authors:  A Hagner-McWhirter; H H Hannesson; P Campbell; J Westley; L Rodén; U Lindahl; J P Li
Journal:  Glycobiology       Date:  2000-02       Impact factor: 4.313

4.  Hydrogen/deuterium exchange-LC-MS approach to characterize the action of heparan sulfate C5-epimerase.

Authors:  Ponnusamy Babu; Xylophone V Victor; Emily Nelsen; Thao Kim Nu Nguyen; Karthik Raman; Balagurunathan Kuberan
Journal:  Anal Bioanal Chem       Date:  2011-05-15       Impact factor: 4.142

5.  Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.

Authors:  Zhenyu Wang; Bo Yang; Zhenqing Zhang; Mellisa Ly; Majde Takieddin; Shaker Mousa; Jian Liu; Jonathan S Dordick; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-12       Impact factor: 4.813

6.  C5-epimerase and 2-O-sulfotransferase associate in vitro to generate contiguous epimerized and 2-O-sulfated heparan sulfate domains.

Authors:  Aurélie Préchoux; Célia Halimi; Jean-Pierre Simorre; Hugues Lortat-Jacob; Cédric Laguri
Journal:  ACS Chem Biol       Date:  2015-01-28       Impact factor: 5.100

7.  A continuous assay for the spectrophotometric analysis of sulfotransferases using aryl sulfotransferase IV.

Authors:  M D Burkart; C H Wong
Journal:  Anal Biochem       Date:  1999-10-01       Impact factor: 3.365

8.  Uncovering biphasic catalytic mode of C5-epimerase in heparan sulfate biosynthesis.

Authors:  Juzheng Sheng; Yongmei Xu; Steven B Dulaney; Xuefei Huang; Jian Liu
Journal:  J Biol Chem       Date:  2012-04-23       Impact factor: 5.157

9.  Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate.

Authors:  Asa Hagner-McWhirter; Jin-Ping Li; Stefan Oscarson; Ulf Lindahl
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

10.  Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability.

Authors:  Adi Goldenzweig; Moshe Goldsmith; Shannon E Hill; Or Gertman; Paola Laurino; Yacov Ashani; Orly Dym; Tamar Unger; Shira Albeck; Jaime Prilusky; Raquel L Lieberman; Amir Aharoni; Israel Silman; Joel L Sussman; Dan S Tawfik; Sarel J Fleishman
Journal:  Mol Cell       Date:  2016-07-14       Impact factor: 17.970

View more
  2 in total

Review 1.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

Review 2.  Physiology and Pathophysiology of Heparan Sulfate in Animal Models: Its Biosynthesis and Degradation.

Authors:  Ryuichi Mashima; Torayuki Okuyama; Mari Ohira
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.